These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22099789)

  • 1. Effect of implementing anti-HLA antibody detection by Luminex in the kidney transplant program in Chile.
    Elgueta S; Fuentes C; López M; Hernández J; Arenas A; Jiménez M; Gajardo JG; Rodríguez H; Labraña C
    Transplant Proc; 2011 Nov; 43(9):3324-6. PubMed ID: 22099789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach.
    Poli F; Cardillo M; Scalamogna M
    Hum Immunol; 2009 Aug; 70(8):631-5. PubMed ID: 19527758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PROCARE consortium: toward an improved allocation strategy for kidney allografts.
    Otten HG; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas M; Spierings E; Hack CE; van Reekum F; van Zuilen AD; Verhaar MC; Bots ML; Seelen MA; Sanders JS; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MG; Vanderlocht J; Voorter CE; Wieten L; van Duijnhoven E; Gelens M; Christiaans M; van Ittersum F; Nurmohamed A; Lardy NM; Swelsen WT; van Donselaar-van der Pant KA; van der Weerd NC; Ten Berge IJ; Bemelman FJ; Hoitsma AJ; de Fijter JW; Betjes MG; Roelen DL; Claas FH
    Transpl Immunol; 2014 Oct; 31(4):184-90. PubMed ID: 25258025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
    Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):505-11. PubMed ID: 26839235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calculated panel reactive antibody method for assessing the probability of kidney recipients to receive transplantation].
    Luo M; Yu L; Xiao L
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):477-81. PubMed ID: 24752091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients.
    Huber L; Lachmann N; Niemann M; Naik M; Liefeldt L; Glander P; Schmidt D; Halleck F; Waiser J; Brakemeier S; Neumayer HH; Schönemann C; Budde K
    Transpl Int; 2015 Jun; 28(6):710-9. PubMed ID: 25639331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
    Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
    Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
    Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
    Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
    Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
    J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probability of deceased donor kidney transplantation based on % PRA.
    Bostock IC; Alberú J; Arvizu A; Hernández-Mendez EA; De-Santiago A; González-Tableros N; López M; Castelán N; Contreras AG; Morales-Buenrostro LE; Gabilondo B; Vilatobá M
    Transpl Immunol; 2013 Jun; 28(4):154-8. PubMed ID: 23684945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches.
    Cecka JM; Kucheryavaya AY; Reinsmoen NL; Leffell MS
    Am J Transplant; 2011 Apr; 11(4):719-24. PubMed ID: 21114658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of time on the deceased donor kidney waitlist versus time on the kidney paired donation registry in the Australian program.
    Ferrari P; Fidler S; Woodroffe C; Tassone G; D'Orsogna L
    Transpl Int; 2012 Oct; 25(10):1026-31. PubMed ID: 22891756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
    Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
    G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrected Panel-Reactive Antibody Positivity Rates for Hypersensitized Patients in Turkish Population With Calculated Panel-Reactive Antibody Software.
    Karadeniz ST; Akgul SU; Ogret Y; Ciftci HS; Bayraktar A; Bakkaloglu H; Caliskan Y; Yelekci K; Turkmen A; Aydin AE; Oguz FS; Carin M; Aydin F
    Transplant Proc; 2017 Apr; 49(3):445-447. PubMed ID: 28340809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.